S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
OTCMKTS:ENZN

Enzon Pharmaceuticals Earnings Date, Estimates & History

$0.61
0.00 (0.00 %)
(As of 02/25/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.50
Now: $0.61
$0.65
50-Day Range
$0.30
MA: $0.52
$0.84
52-Week Range
$0.02
Now: $0.61
$0.85
Volume79,062 shs
Average Volume442,745 shs
Market Capitalization$45.61 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77

Earnings

Enzon Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 3rd, 2021 based off prior year's report dates.

Enzon Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Enzon Pharmaceuticals (OTCMKTS ENZN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/3/2021
(Estimated)
       
7/29/2020Q2 2020($0.01)($0.01)$0.01 millionN/A
4/30/2020Q1 2020($0.01)($0.01)N/A
5/8/2019Q1 2019($0.01)($0.01)($0.05) millionN/A
2/21/2019Q4 2018$0.15$0.15$7.12 millionN/A
11/7/2018Q3 2018($0.01)($0.01)($0.28) millionN/A
8/10/2018Q2 2018($0.01)($0.01)$0.06 millionN/A
5/10/2018Q1 2018($0.01)($0.01)$0.02 millionN/A
3/21/2018Q4 2017$0.01$0.01$0.01 millionN/A
8/10/2017Q2 2017$0.09$0.09$6.78 millionN/A
5/11/2017Q1 2017$0.01$0.01$1.44 millionN/A
3/24/2017Q4 2016($0.10)($0.10)$0.85 millionN/A
11/10/2016Q3 2016$0.02$0.02$1.99 millionN/A
8/10/2016Q3 2016$0.02$0.02$2.27 millionN/A
5/9/2016Q1 2016$0.03$0.03$3.27 millionN/A
3/21/2016Q4 2015$0.28$0.28$3.16 millionN/A
11/6/2015Q3 2015($0.04)($0.04)$3.84 millionN/A
8/7/2015Q2 2015$0.09$0.09$5.19 millionN/A
5/13/2015Q1 2015$0.16$0.16$5.26 millionN/A
3/5/2015Q4 2014$0.13$0.13$6.27 millionN/A
11/6/2014Q3 2014$0.17$0.17$8.16 millionN/A
8/8/2014Q2 2014$0.16$0.16$7.77 millionN/A
5/9/2014Q1 2014$0.19$0.19$8.98 millionN/A
3/14/2014Q4 2013$0.12$0.12$7.43 millionN/A
11/12/2013Q3 2013$0.13$0.13$8.83 millionN/A
8/6/2013Q2 2013$0.09$0.09$8.06 millionN/A
5/10/2013Q1 2013$0.05$0.05$10.40 million$10.18 millionN/A
3/18/2013Q4 2012($0.11)$10.01 million$10.65 millionN/A
10/31/2012Q3 2012$0.02$0.08$0.08N/A
8/1/2012Q2 2012($0.02)($0.02)N/A
5/2/2012Q1 2012($0.02)($0.02)N/A
3/12/2012Q4 2011($0.08)($0.06)N/A
11/3/2011Q3 2011($0.14)($0.09)N/A
8/4/2011Q2 2011($0.12)($0.11)N/A
5/6/2011Q1 2011($0.01)($0.07)($0.15)N/A
2/17/2011Q4 2010($0.08)($0.13)($0.08)N/A
11/2/2010Q3 2010($0.04)($0.13)($0.12)N/A
8/3/2010Q2 2010($0.06)($0.08)($0.07)N/A
5/10/2010Q1 2010($0.15)($0.13)($2.96)N/A
8/4/2009Q2 2009($0.04)($0.11)($0.11)N/A
5/7/2009Q1 2009($0.07)$0.04($0.04)N/A
2/19/2009Q4 2008($0.13)($0.01)($0.01)N/A
11/5/2008Q3 2008($0.15)($0.05)($0.05)N/A
8/6/2008Q2 2008($0.10)($0.01)$0.02N/A
5/7/2008Q1 2008($0.08)$0.03$0.03N/A
2/14/2008Q4 2007($0.16)$0.02$0.03N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.